A carregar...

Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation

Bapineuzumab is a humanized antibody developed by Pfizer and Johnson & Johnson targeting the amyloid (Aβ) plaques that underlie Alzheimer's disease neuropathology. Here we report the crystal structure of a Fab-Aβ peptide complex that reveals Bapineuzumab surprisingly captures Aβ in a monome...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Miles, Luke A., Crespi, Gabriela A. N., Doughty, Larissa, Parker, Michael W.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3575012/
https://ncbi.nlm.nih.gov/pubmed/23416764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep01302
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!